Sundrug Co stock forecast
Sundrug Co (SDGCF) Stock Forecast & Price Target
SDGCF Analyst Ratings
SDGCF Stock 12 Month Forecast
Average Price Target
$26.37▲(9.20% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
 Unknown AnalystNot Ranked | J.P. Morgan | $25.90 | hold | 7.28%Upside | Reiterated | 11/04/26 | ||
| Unknown AnalystNot Ranked | UBS | $25.46→$24.13 | hold | -0.05%Downside | Reiterated | 10/06/26 | ||
| Unknown AnalystNot Ranked | Bank of America Securities | $29.06 | buy | 20.36%Upside | Reiterated | 08/17/26 | ||
| Unknown AnalystNot Ranked | SMBC Nikko | $26.53 | hold | 9.89%Upside | Reiterated | 06/03/26 | ||
| Unknown AnalystNot Ranked | Mizuho Securities | $32.22 | buy | 33.44%Upside | Reiterated | 05/22/26 | ||
| Unknown AnalystNot Ranked | Iwai Cosmo | $34.11 | buy | 41.29%Upside | Reiterated | 12/12/25 | ||
| Hisahiro Yamaoka | Nomura | $35.38 | buy | 46.52%Upside | Reiterated | 12/01/25 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Unknown AnalystJ.P. MorganNot Ranked | HoldReiterated$25.90 | 11/04/26 | 7.28%Upside | ||
| Unknown AnalystUBSNot Ranked | HoldReiterated$25.46→$24.13 | 10/06/26 | -0.05%Downside | ||
| Unknown AnalystBank of America SecuritiesNot Ranked | BuyReiterated$29.06 | 08/17/26 | 20.36%Upside | ||
| Unknown AnalystSMBC NikkoNot Ranked | HoldReiterated$26.53 | 06/03/26 | 9.89%Upside | ||
| Unknown AnalystMizuho SecuritiesNot Ranked | BuyReiterated$32.22 | 05/22/26 | 33.44%Upside | ||
| Unknown AnalystIwai CosmoNot Ranked | BuyReiterated$34.11 | 12/12/25 | 41.29%Upside | ||
| Hisahiro YamaokaNomura | BuyReiterated$35.38 | 12/01/25 | 46.52%Upside |
Best Analysts Covering Sundrug Co
Copying xAi Medical - Pharmaceuticals's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -5.15% per trade.
Copying xAi Medical - Pharmaceuticals's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -10.00% per trade.
Copying xAi Medical - Pharmaceuticals's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of -10.00% per trade.
SDGCF Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 0 |
| Hold | 3 | 3 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 4 | 4 | 3 | 3 | 2 |
In the current month, SDGCF has received 0 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. SDGCF average Analyst price target in the past 3 months is 26.37.
SDGCF Financial Forecast
SDGCF Earnings Forecast
Next quarter’s earnings estimate for SDGCF is $0.39 with a range of $0.39 to $0.39. The previous quarter’s EPS was $0.43. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
SDGCF Sales Forecast
Next quarter’s sales forecast for SDGCF is $1.37B with a range of $1.37B to $1.38B. The previous quarter’s sales results were $1.35B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
